Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Connected With Latham

Connected With Latham artwork

Episode 125 – Drug Pricing and Market Access: The RAPID Pathway

Sep 21, 202634 minAudio

The Centers for Medicare & Medicaid Services (CMS) proposed the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway to coordinate FDA device approval and Medicare coverage decisions under one coordinated process from the start - aiming to shrink a historically five-year gap to as few as 60-90 days. In this episode of Connected With Latham, Washington, D.C. partners Chris Schott and Nate Beaton, along with associate Danny Machado, break down how RAPID works, how it differs from prior coverage initiatives, and what device manufacturers should consider as the pathway takes shape. Also check out our bi-weekly Drug Pricing Digest on the website or subscribe to receive future editions in your inbox. This podcast is provided as a service of Latham & Watkins LLP. Listening to this podcast does not create an attorney client relationship between you and Latham & Watkins LLP, and you should not send confidential information to Latham & Watkins LLP. While we make every effort to assure that the content of this podcast is accurate, comprehensive, and current, we do not warrant or guarantee any of those things and you may not rely on this podcast as a substitute for legal research and/or consulting a qualified attorney. Listening to this podcast is not a substitute for engaging a lawyer to advise on your individual needs. Should you require legal advice on the issues covered in this podcast, please consult a qualified attorney. Under New York's Code of Professional Responsibility, portions of this communication contain attorney advertising. Prior results do not guarantee a similar outcome. Results depend upon a variety of factors unique to each representation. Please direct all inquiries regarding the conduct of Latham and Watkins attorneys under New York's Disciplinary Rules to Latham & Watkins LLP, 1271 Avenue of the Americas, New York, NY 10020, Phone: 1.212.906.1200

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Episode 132 – Shining a Light on the Sunshine Act and Transparency Requirements: Rules of the Road in Europe

    Nov 19, 202621 minAudio

    France requires pharmaceutical and medical device companies to publicly disclose their agreements with a broad range of healthcare beneficiaries, along with the payments and benefits they provide - no matter where the...

    Credit the people on this episode

  2. Episode 131 – Sports as an Asset Class: Human Competition in the Age of AI

    Nov 16, 202627 minAudio

    Sports has become a sought-after asset class for private equity sponsors, lenders, family offices, and strategic operators. So where do leading investors see the next opportunities in live sports? Join New York partners...

    Credit the people on this episode

  3. Episode 130 – The Growth Rocketship: Proving Cloud Security and AI at AWS

    Nov 12, 20261 hr 3 minAudio

    Launched in 2006, Amazon Web Services (AWS) now powers millions of customers worldwide with on-demand infrastructure, storage, and AI services. In 2016, Byron Cook founded the Automated Reasoning Group within AWS,...

    Credit the people on this episode

  4. Episode 129 – The Growth Rocketship: The Future of the Open Internet With Animoca Brands

    Oct 29, 20261 hr 17 minAudio

    Originally founded with a focus on mobile gaming, Animoca Brands has since evolved into one of the most prolific investors in Web3, with a portfolio spanning across AI, institutional-grade platforms, DeFi, and...

    Credit the people on this episode

  5. Episode 128 – Drug Pricing and Market Access: Takeaways from the Medicaid Drug Rebate Program Summit 2026

    Oct 21, 202643 minAudio

    Stakeholders from across the healthcare industry recently convened in Chicago for the Medicaid Drug Rebate Program Summit 2026. In this episode of Connected With Latham, Washington, D.C. partner Chris Schott discusses...

    Credit the people on this episode